1-6 of 360 Activities
In this CME Outfitters recorded symposium, faculty will discuss the integration of guideline-based universal testing to address screening gaps for HIV, HBV, and HCV; evaluate pan-viral testing strategies that improve engagement in diverse practice settings; and explore strategies to incorporate guideline-recommended pan-viral and perinatal screenings into the care of patients who are pregnant to improve outcomes and limit perinatal transmission.
In this CME Outfitters recorded symposium, expert faculty will discuss the disease burden and impact of LGS on QoL for patients and caregivers, the utilization of diagnostic criteria and distinguishing features of both early- and late-onset LGS to achieve early and accurate diagnosis, and strategies to optimize LGS management across the lifespan of these patients.
This educational initiative aims to enhance clinician competence in evaluating the efficacy and safety of FcRn and C5 complement inhibitors and integrating formal HRQoL assessments, such as the MG-QOL15r, into gMG management. By bridging these gaps, healthcare providers can optimize treatment strategies, improve patient outcomes, and address the unmet needs of those living with gMG.
In this CMEO Snack, expert faculty will share strategies for identifying aligned HEDIS measures pertaining to HIV care, integrating quality measures as a standardized process in clinical practice, as well as documenting the utilization of quality measures to assess impact of quality care on patient outcomes.
In this CME Outfitters Snack, expert faculty, including OB/GYNs, will address the educational needs of providers who care for patients with or at risk for HIV, explaining how to discuss HIV risk with patients and the latest guideline-based care and recommendations for those with or at risk of HIV considering pregnancy or who are currently pregnant.
In this CME Outfitters Snack, expert faculty, including dermatologists, will address the educational needs of dermatology providers and other HCPs including improving their knowledge of the efficacy and safety data for novel and emerging therapies in PsO, discussing clinical experiences, current and late-breaking research, and how to integrate this data into their management of patients with PsO.
